We did not carry out RNAseq on our IL-6 exposed NPC RNA, so we cannot discount a non-canonical response to IL-6 that is independent of the IL6Ra-STAT3 pathway at higher concentrations of IL-6. The gene discussed is STAT3; the disease is nasopharyngeal carcinoma.